| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.47 | 0.1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.42 | 0.1 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.41 | 0.2 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.32 | 0.3 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.23 | 0.05 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.19 | 0.003 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.08 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.18 | 0.1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.16 | 0.4 |